Here are the most-read GI stories during the week of Feb. 22-26:
GI & Endoscopy
Solvd Health is developing a colorectal neoplasia test that detects precancerous polyps with 90 percent accuracy.
Here are six updates from GI companies and practices:
CRH Medical signed a new five-year exclusive management services agreement with United Digestive after months of negotiations.
For patients with complex benign colorectal polyps, surgical intervention tends to be the norm. Yet, endoluminal procedures like endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) offer better alternatives.
Salisbury, Md.-based TidalHealth Gastroenterology moved its office to a medical park.
The new year has coincided with a rapid increase in private equity investment in the gastroenterology space.
Here are three updates on gastroenterology-driven ASCs in January:
Concord, Mass.-based Emerson Hospital and Acton, Mass.-based Middlesex Digestive Health are performing endoscopic ultrasounds at Emerson Hospital, making it one of the first hospitals in the region to offer the procedure.
The American Gastroenterological Association endorsed a clinical decision support tool providers can use to recommend biologic therapies for patients with inflammatory bowel disease, the society announced Feb. 18.
